ENDRA Life Sciences
ApprovedENDRA is focused on early detection of liver disease. TAEUS® is a new, proprietary way to measure fat in the liver that is now CE-marked for sale in Europe. The technology is non-invasive and costs 50x less than MRI.
Founded
2009
Focus
Medical DevicesDiagnostics
About
ENDRA is focused on early detection of liver disease. TAEUS® is a new, proprietary way to measure fat in the liver that is now CE-marked for sale in Europe. The technology is non-invasive and costs 50x less than MRI.
Funding History
4Total raised: $26.5M
IPO$10MUndisclosedJun 30, 2017
Series B$10MUndisclosedMay 15, 2017
Series A$5MUndisclosedMar 15, 2015
Seed$1.5MUndisclosedJun 15, 2013
Company Info
TypePrivate
Founded2009
LocationAnn Arbor, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile